Skip to content

BODY-Q Longitudinal Result Study and Comparison With Normative Scores

Longitudinal Follow-up and Comparison of Bariatric and Post-bariatric Body Contouring Patient's Health-related Quality of Life Relative to Population Norms Using the BODY-Q

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05272215
Enrollment
20000
Registered
2022-03-09
Start date
2015-06-30
Completion date
2022-05-31
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excess Skin, Weight Loss

Keywords

Bariatric surgery, Massive weight loss, Body contouring surgery, Health-related quality of life, Quality of life, Post bariatric surgery

Brief summary

Obesity is a global epidemic that has nearly tripled since 1975. Worldwide, over 650 million people live with obesity, and it is therefore a growing cause for concern. Bariatric surgery (BaS) is the most effective long-term weight loss method in morbidly obese patients. BaS can result in sustained weight loss and resolve obesity-related comorbidities. However, BaS most often results in various extremes of excess skin, where subsequent body contouring surgery (BC) can be needed. The excess skin following massive weight loss is known to negatively impacts patients' body image, physical and psychological well-being, which previous studies have indicated to improve after BC. The purpose of this study is to assess change in patients' health-related quality of life (HRQL) relative to the general population score. To the best of our knowledge, there are no studies measuring change of patient's HRQL throughout the entire weight loss journey and comparing these scores with the scores of the general population. It is hypothesized that 1) BaS will improve patients' quality of life on short terms (1-2 years) after surgery, however patients' HRQL will decrease with increasing amounts of excess skin. 2) Patients' HRQL will improve after post-BC equivalent of the scores of the general population.

Detailed description

HRQL is best measured through patient-reported outcomes (PRO), defined as a patient evaluation of outcomes without interference from clinicians or any other intermediary. A vast array of patient-reported outcome measure (PROM)s have been used in weight loss and BC patients, many of which do not possess strong evidence of reliability and validity for the patient population. In 2016, The BODY-Q, a condition-specific PROM developed following internationally recommended guidelines to measure PRO in weight loss, including bariatric surgery, and body contouring surgery (BC) patients were introduced. It consists of 32 independently functioning scales measuring four domains: appearance, HRQL, eating-related concerns, and patient experience of care. It is rigorously tested to ensure content validity, reliability, and responsiveness. Due to the strongest evidence for validity and its psychometric properties, recent systematic review based on the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) methodology only recommend the BODY-Q for use in this patient population. The BODY-Q has been shown to be responsive to change and subsequently to measure change over the entire weight loss trajectory, i.e., from obesity to weight loss with or without BC. In previous studies, the BODY-Q has been used to demonstrate the efficacy of weight loss therapy and BC. However, a current limitation of the BODY-Q is the lack of general population norms as a reference value of the four domains (HRQL, appearance, eating-related concerns, and experience of care). To date, it is not known how published preoperative and postoperative scores compare to population norms, enabling a better understanding of HRQL of obesity and change through the weight loss trajectory. The primary aim of this study is to investigate the change of HRQL through the entire weight loss journey from obesity to post-BC in a longitudinal, prospective cohort study of Danish patients. The study will be performed as part of an international collaboration and Danish data will be merged with data from the Netherlands, Finland, Poland, Italy, Germany, and the United States. The secondary aim of this study is to compare international patient results with the general population norms. The general population norms. Currently, the general population norms study is under submission.

Interventions

PROCEDUREBariatric surgery

Pre- and post-bariatric surgery (3, 6, 12 months postoperative and yearly)

Pre- and post body contouring surgery (3, 6, 12 months postoperative and yearly)

Sponsors

Hospital of Southwest Jutland, Esbjerg, Denmark
CollaboratorUNKNOWN
McMaster University
CollaboratorOTHER
OLVG West Hospital, Amsterdam, the Netherlands
CollaboratorUNKNOWN
Catharina Ziekenhuis Eindhoven
CollaboratorOTHER
Tampere University Hospital
CollaboratorOTHER
Department of Plastic Surgery, Wroclaw, Poland
CollaboratorUNKNOWN
Department of Plastic Surgery, Eberhard Karls Universität Tübingen, Tübingen, Germany
CollaboratorOTHER
Campus Bio-Medico University
CollaboratorOTHER
Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pre- and post-bariatric surgery patients * Pre- and post body contouring surgery patients * Fluent in Danish

Exclusion criteria

* Patients who do not speak Danish * Patients with cognitive impairments * Patients who have not undergone BaS/BC

Design outcomes

Primary

MeasureTime frameDescription
BODY-Q Health-related quality of life (HRQL) domainJune 2015 to May 2022Following scales are included: 1. Appearance distress 2. Body image 3. Physical function 4. Physical symptoms 5. Psychological 6. Sexual 7. Social 8. Work life

Secondary

MeasureTime frameDescription
Comparison of patient scores to general population normative scoresJune 2015 to May 2022The scores of patients will be compared to the general population normative scores to assess the impact of BaS and BC on patients' lives compared to the general population HRQL.

Countries

Denmark

Contacts

Primary ContactFarima Dalaei, MD
farima.dalaei@gmail.com+45 28823662

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026